Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1266202.RAqP7wUBNoECMHziU4MB70RN-L4tccLHKnRPAnJRbB48w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1266202.RAqP7wUBNoECMHziU4MB70RN-L4tccLHKnRPAnJRbB48w130_assertion type Assertion NP1266202.RAqP7wUBNoECMHziU4MB70RN-L4tccLHKnRPAnJRbB48w130_head.
- NP1266202.RAqP7wUBNoECMHziU4MB70RN-L4tccLHKnRPAnJRbB48w130_assertion description "[Copy number analyses by molecular inversion probe assays of the three spindle cell carcinoma samples revealed little overall genomic CNAs with only minor changes identified (fraction of the genome altered; 1.3%-6.4%), but with a common 9p21.3 loss in 2 out of 3 samples, with CDKN2A (p16) being a likely candidate.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1266202.RAqP7wUBNoECMHziU4MB70RN-L4tccLHKnRPAnJRbB48w130_provenance.
- NP1266202.RAqP7wUBNoECMHziU4MB70RN-L4tccLHKnRPAnJRbB48w130_assertion evidence source_evidence_literature NP1266202.RAqP7wUBNoECMHziU4MB70RN-L4tccLHKnRPAnJRbB48w130_provenance.
- NP1266202.RAqP7wUBNoECMHziU4MB70RN-L4tccLHKnRPAnJRbB48w130_assertion SIO_000772 25713418 NP1266202.RAqP7wUBNoECMHziU4MB70RN-L4tccLHKnRPAnJRbB48w130_provenance.
- NP1266202.RAqP7wUBNoECMHziU4MB70RN-L4tccLHKnRPAnJRbB48w130_assertion wasDerivedFrom befree-2016 NP1266202.RAqP7wUBNoECMHziU4MB70RN-L4tccLHKnRPAnJRbB48w130_provenance.
- NP1266202.RAqP7wUBNoECMHziU4MB70RN-L4tccLHKnRPAnJRbB48w130_assertion wasGeneratedBy ECO_0000203 NP1266202.RAqP7wUBNoECMHziU4MB70RN-L4tccLHKnRPAnJRbB48w130_provenance.